Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/25884399/ below:

Effects of payer status on breast cancer survival: a retrospective study

Affiliations

• ¹ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. rshi@lsuhsc.edu.
• ² Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. htayl2@lsuhsc.edu.
• ³ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. jmclar@lsuhsc.edu.
• ⁴ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. lliu1@lsuhsc.edu.
• ⁵ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. gmills@lsuhsc.edu.
• ⁶ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. gburto@lsuhsc.edu.

• PMID: 25884399
• PMCID: PMC4383189
• DOI: 10.1186/s12885-015-1228-7

Item in Clipboard

Runhua Shi et al. BMC Cancer. 2015.

• ¹ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. rshi@lsuhsc.edu.
• ² Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. htayl2@lsuhsc.edu.
• ³ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. jmclar@lsuhsc.edu.
• ⁴ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. lliu1@lsuhsc.edu.
• ⁵ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. gmills@lsuhsc.edu.
• ⁶ Department of Medicine & Feist-Weiller Cancer Center, LSU Health Shreveport, 1501 Kings Hwy, Shreveport, LA, 71103, USA. gburto@lsuhsc.edu.

• PMID: 25884399
• PMCID: PMC4383189
• DOI: 10.1186/s12885-015-1228-7

Item in Clipboard

Background: Breast cancer outcomes are influenced by multiple factors including access to care, and payer status is a recognized barrier to treatment access. To further define the influence of payer status on outcome, the National Cancer Data Base data from 1998-2006 was analyzed.

Method: Data was analyzed from 976,178 female patients diagnosed with breast cancer registered in the National Cancer Data Base. Overall survival was the primary outcome variable while payer status was the primary predictor variable. Secondary predictor variables included stage, age, race, Charlson Comorbidity index, income, education, distance travelled, cancer program, diagnosing/treating facility, and treatment delay. Multivariate Cox regression was used to investigate the effect of payer status on overall survival while adjusting for secondary predictive factors.

Results: Uninsured (28.68%) and Medicaid (28.0%) patients had a higher percentage of patients presenting with stage III and stage IV cancer at diagnosis. In multivariate analysis, after adjusting for secondary predictor variables, payer status was a statistically significant predictor of survival. Patients with private, unknown, or Medicare status showed a decreased risk of dying compared to uninsured, with a decrease of 36%, 22%, and 15% respectively. However, Medicaid patients had an increased risk of 11% compared to uninsured. The direct adjusted median overall survival was 14.92, 14.76, 14.56, 13.64, and 12.84 years for payer status of private, unknown, Medicare, uninsured, and Medicaid respectively.

Conclusion: We observed that patients with no insurance or Medicaid were most likely to be diagnosed at stage III and IV. Payer status showed a statistically significant relationship with overall survival. This remained true after adjusting for other predictive factors. Patients with no insurance or Medicaid had higher mortality.

PubMed Disclaimer

Direct adjusted survivor functions for…

Direct adjusted survivor functions for payer status. Direct adjusted median overall survival (MOS)…

Direct adjusted survivor functions for payer status. Direct adjusted median overall survival (MOS) was 14.9, 14.8, 14.6, 13.6, and 12.8 years for private, unknown, Medicare, uninsured, and Medicaid respectively.

• The Effect of Payer Status on Survival of Patients with Stage I/II Non-small Cell Lung Cancer: NCDB 1998-2011.

  Shi R, Diaz R, Shi Z, Duvall E, Mills G. Shi R, et al. Anticancer Res. 2016 Jan;36(1):319-26. Anticancer Res. 2016. PMID: 26722060

• Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database.

  Master S, Munker R, Shi Z, Mills G, Shi R. Master S, et al. Anticancer Res. 2016 Sep;36(9):4915-21. doi: 10.21873/anticanres.11057. Anticancer Res. 2016. PMID: 27630349

• Private Payer's Status Improves Male Breast Cancer Survival.

  Shi R, Taylor H, Liu L, Mills G, Burton G. Shi R, et al. Breast J. 2016 Jan-Feb;22(1):101-4. doi: 10.1111/tbj.12523. Epub 2015 Oct 28. Breast J. 2016. PMID: 26511322

• Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.

  Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Halpern MT, et al. Lancet Oncol. 2008 Mar;9(3):222-31. doi: 10.1016/S1470-2045(08)70032-9. Epub 2008 Feb 20. Lancet Oncol. 2008. PMID: 18282806

• Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.

  Yao K, Winchester DJ, Czechura T, Huo D. Yao K, et al. Breast Cancer Res Treat. 2013 Dec;142(3):465-76. doi: 10.1007/s10549-013-2745-1. Epub 2013 Nov 12. Breast Cancer Res Treat. 2013. PMID: 24218052 Review.

• Geospatial Hot Spots and Cold Spots in US Cancer Disparities and Associated Risk Factors, 2004-2008 to 2014-2018.

  Guo LR, Hughes MC, Wright ME, Harris AH, Osias MC. Guo LR, et al. Prev Chronic Dis. 2024 Oct 31;21:E84. doi: 10.5888/pcd21.240046. Prev Chronic Dis. 2024. PMID: 39481013 Free PMC article.

• Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage.

  Martinez-Cannon BA, Zertuche-Maldonado T, de la Rosa Pacheco S, Cardona-Huerta S, Canavati-Marcos M, Gomez-Macias GS, Villarreal-Garza C. Martinez-Cannon BA, et al. Womens Health (Lond). 2020 Jan-Dec;16:1745506520949416. doi: 10.1177/1745506520949416. Womens Health (Lond). 2020. PMID: 32811351 Free PMC article.

• The role of education on Cancer amenable mortality among non-Hispanic blacks & non-Hispanic whites in the United States (1989-2018).

  Barcelo A, Duffett-Leger L, Pastor-Valero M, Pereira J, Colugnati FAB, Trapido E. Barcelo A, et al. BMC Cancer. 2021 Sep 7;21(1):907. doi: 10.1186/s12885-021-08633-7. BMC Cancer. 2021. PMID: 34493242 Free PMC article.

• Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer.

  Obeng-Gyasi S, O'Neill A, Zhao F, Kircher SM, Lava TR, Wagner LI, Miller KD, Sparano JD, Sledge GW, Carlos RC. Obeng-Gyasi S, et al. Cancer Med. 2021 Jan;10(1):45-52. doi: 10.1002/cam4.3542. Epub 2020 Dec 2. Cancer Med. 2021. PMID: 33264502 Free PMC article.

• Race/ethnicity and socio-economic differences in colorectal cancer surgery outcomes: analysis of the nationwide inpatient sample.

  Akinyemiju T, Meng Q, Vin-Raviv N. Akinyemiju T, et al. BMC Cancer. 2016 Sep 5;16(1):715. doi: 10.1186/s12885-016-2738-7. BMC Cancer. 2016. PMID: 27595733 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3